Ribon Therapeutics, Inc. logo

Ribon Therapeutics, Inc.

Ribon Therapeutics is pioneering the discovery and development of monoPARP (mono ADP-ribose polymerase) inhibitors to block cancer cells’ fundamental ability to survive under stress.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.ribontx.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
99 Hayden Avenue, MA, 02421
Lexington
United States
Email
Contact Number
+1 617-914-8700

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/ribon-therapeutics” connections=”true” suffix=””]